Why the study?
An increasing number of patients on anticoagulant or antiplatelet therapy after PCI or other cardiac interventions require non-postponable surgery, necessitating guidance on perioperative bridging and therapy discontinuation.
This review highlights the modern approach to perioperative management of patients on antithrombotic therapy, advocating for individualized multidisciplinary risk assessment and reduced reliance on routine bridging therapy.
In modern world it is really important to know how to manage patients taking anticoagulant or antiplatelet therapy. There is an increasing number of patients, who have gone through PCI or any other cardiac intervention and who also need another surgery which cannot be postponed till the end of dual antiplatelet therapy. The number of patients who take oral anticoagulant has also increased last years. Algorithms of perioperative bridging therapy and antiplatelet therapy discontinuation can help to decrease both ischemic and hemorrhagic complications. Multidisciplinary risk assessment remains a critical component of perioperative care.
No takes yet. Share an insight, caveat, or question.
Pavlenko et al. (2022) conducted a review in Patients on antithrombotic therapy requiring surgery. Perioperative bridging therapy and antithrombotic discontinuation algorithms was evaluated. Individualized algorithms for perioperative bridging therapy and antithrombotic discontinuation, guided by multidisciplinary risk assessment, are essential to minimize ischemic and hemorrhagic complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: